The Melatonin Adjunct in the Acute myocaRdial Infarction Treated With Angioplasty (MARIA)
This study is ongoing, but not recruiting participants.
Alberto Dominguez-Rodriguez, MD, PhD, FESC
Information provided by (Responsible Party):
Alberto Dominguez-Rodriguez, MD, PhD, FESC, Fundación Canaria Rafael Clavijo para la Investigación Biomédica
First received: March 12, 2008
Last updated: April 21, 2016
Last verified: April 2016
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is ongoing, but not recruiting participants.|
|Estimated Study Completion Date:||November 2016|
|Primary Completion Date:||March 2016 (Final data collection date for primary outcome measure)|
Dominguez-Rodriguez A, Abreu-Gonzalez P, Garcia-Gonzalez MJ, Kaski JC, Reiter RJ, Jimenez-Sosa A. A unicenter, randomized, double-blind, parallel-group, placebo-controlled study of Melatonin as an Adjunct in patients with acute myocaRdial Infarction undergoing primary Angioplasty The Melatonin Adjunct in the acute myocaRdial Infarction treated with Angioplasty (MARIA) trial: study design and rationale. Contemp Clin Trials. 2007 Jul;28(4):532-9. Epub 2006 Oct 17.